News
-
Swiss Medtech Sector Faces Uncertainty Amid U.S. Tariff Changes – Swiss Medtech and CH-REPs Call for Diplomatic and Regulatory Action
April 12, 2025 – The Swiss medical technology industry faces growing uncertainty following the U.S. government's recent decision to impose import tariffs on countries with trade surpluses. With a considerable surplus, Switzerland has been hit with a 31% tariff—significantly higher than many other nations. This move directly threatens the Swiss…